Published in Clin Exp Metastasis on January 01, 1999
Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med (2001) 5.97
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation. Blood (2009) 1.16
Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis (2007) 0.97
Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma. PLoS One (2012) 0.96
The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol (2011) 0.90
Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo. Leukemia (2015) 0.81
Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. Clin Exp Metastasis (2003) 0.80
Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma. J Cell Biochem (2016) 0.78
Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment. Blood Cancer J (2016) 0.75
Microenvironment drug resistance in multiple myeloma: emerging new players. Oncotarget (2016) 0.75
A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro. Int J Mol Sci (2017) 0.75
Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model. Biomed Res Int (2017) 0.75
Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders. Indian J Hematol Blood Transfus (2017) 0.75
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med (1990) 3.78
CD44: structure, function, and association with the malignant process. Adv Cancer Res (1997) 3.66
Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood (1990) 3.65
Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science (1997) 3.28
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med (1996) 2.37
The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol (1999) 1.79
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev (1988) 1.75
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res (1999) 1.41
Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol (1996) 1.41
CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol (1997) 1.40
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res (1997) 1.25
Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J Immunol (1994) 1.17
Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res (1998) 1.05
Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res (1998) 1.04
Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J Immunol (1999) 1.04
Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem (1997) 0.99
Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate. Cancer Res (1998) 0.98
Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells. Exp Cell Res (1998) 0.97
A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells. Clin Exp Metastasis (1994) 0.94
Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. Int J Cancer (1995) 0.90
Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J Immunol (1999) 0.89
Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration. J Immunol (1998) 0.87
Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro. Clin Exp Metastasis (1998) 0.81
Functions of domain 1 and 4 of vascular cell adhesion molecule-1 in alpha4 integrin-dependent adhesion under static and flow conditions are differentially regulated. J Immunol (1996) 0.80
Expression of retrovirally transduced IL-1 alpha in IL-6-dependent B cells: a murine model of aggressive multiple myeloma. Growth Factors (1991) 0.80
Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44. Exp Cell Res (1999) 0.79
Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature. Proc Natl Acad Sci U S A (1997) 0.76
Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas. Clin Exp Metastasis (1993) 0.75
Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res (1993) 3.59
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Inhibition of nuclear hormone receptor activity by calreticulin. Nature (1994) 2.11
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther (2000) 2.01
Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc Natl Acad Sci U S A (1987) 1.81
The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immunol (2000) 1.80
Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat Biotechnol (1996) 1.70
Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr Biol (1995) 1.67
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
AKAP350, a multiply spliced protein kinase A-anchoring protein associated with centrosomes. J Biol Chem (1999) 1.49
Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res (1991) 1.43
Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation. Blood (1999) 1.42
A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation. Blood (1996) 1.40
Molecular cloning of an immunoglobulin kappa constant gene from NZB mouse. Gene (1981) 1.37
Retroperitoneal haematoma due to ruptured microaneurysm of the pancreaticoduodenal artery. J Gastroenterol Hepatol (1993) 1.37
Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J (1999) 1.33
Long- and short-lived murine hematopoietic stem cell clones individually identified with retroviral integration markers. Blood (1990) 1.30
Leptin receptor action in hepatic cells. J Biol Chem (1997) 1.29
Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood (1995) 1.28
Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc Natl Acad Sci U S A (2001) 1.22
Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis. Blood (2000) 1.21
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells. Blood (2001) 1.17
A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther (1997) 1.16
BDNF upregulation during declarative memory formation in monkey inferior temporal cortex. Nat Neurosci (2000) 1.16
Decreased expression of cold-inducible RNA-binding protein (CIRP) in male germ cells at elevated temperature. Am J Pathol (1998) 1.12
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res (1995) 1.12
A method for the histopathological analysis of the temporal bone and the eustachian tube and its accessory structures. Ann Otol Rhinol Laryngol (1986) 1.11
Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem (1996) 1.07
Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance. J Med Chem (2001) 1.06
Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol Cell Biol (1998) 1.04
Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int J Oncol (1999) 1.03
Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. Blood (1998) 1.02
High-level expression of human c-jun gene causes cellular transformation of chicken embryo fibroblasts. Jpn J Cancer Res (1991) 1.00
Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells. Plasmid (1989) 1.00
Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp Hematol (1990) 1.00
Expression mapping of adhesion receptor genes during differentiation of individual hematopoietic precursors. Exp Hematol (1997) 0.99
The evolution of the fraction of Er ions sensitized by Si nanostructures in silicon-rich silicon oxide thin films. Nanotechnology (2009) 0.97
Four-color flow cytometric detection of retrovirally expressed red, yellow, green, and cyan fluorescent proteins. Biotechniques (2001) 0.97
Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6. J Immunol Methods (1992) 0.97
Seminal tract obstruction caused by childhood inguinal herniorrhaphy: results of microsurgical reanastomosis. J Urol (1998) 0.96
HOX11 interacts with CTF1 and mediates hematopoietic precursor cell immortalization. Oncogene (1999) 0.95
Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood (1998) 0.94
A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells. Clin Exp Metastasis (1994) 0.94
Prevention of autoimmune disease by retroviral-mediated gene therapy. J Immunol (1995) 0.93
Leukemic predisposition of mice transplanted with gene-modified hematopoietic precursors expressing flt3 ligand. Blood (1998) 0.93
TALE homeoproteins as HOX11-interacting partners in T-cell leukemia. Leuk Lymphoma (2000) 0.92
TLX1/HOX11-induced hematopoietic differentiation blockade. Oncogene (2007) 0.91
Establishment of a novel factor-dependent myeloid cell line from primary cultures of mouse bone marrow. Cytokine (1991) 0.91
Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11. Biochem Biophys Res Commun (1994) 0.91
Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes. J Cell Physiol (1990) 0.91
Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements. Int J Cancer (1995) 0.90
"Rainbow" reporters for multispectral marking and lineage analysis of hematopoietic stem cells. Stem Cells (2001) 0.89
Preparation of platinum nanoparticles by sonochemical reduction of the Pt(IV) ions: role of surfactants. Ultrason Sonochem (2001) 0.89
How to remove, process, and study the temporal bone with the entire eustachian tube and its accessory structures: a method for histopathological study. Auris Nasus Larynx (1985) 0.88
Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma. Cancer Gene Ther (2001) 0.88
Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J Immunol (1996) 0.88
Configurational encoding of complex visual forms by single neurons of monkey temporal cortex. Neuropsychologia (1993) 0.87
Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver. Jpn J Pharmacol (1986) 0.87
Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. J Urol (1999) 0.87
Interferon-beta interrupts interleukin-6-dependent signaling events in myeloma cells. Blood (1997) 0.85
Allelic exclusion and differentiation by protein kinase C-mediated signals in immature thymocytes. Proc Natl Acad Sci U S A (2001) 0.85
Quantitative analysis of testicular histology in patients with vas deferens obstruction caused by childhood inguinal herniorrhaphy: comparison to vasectomized men. J Urol (1996) 0.85
Direct evaluation of stereoselectivity of cancer esterases by polyacrylamide gel electrophoresis coupled with activity staining with chiral naphthyl esters. Anal Biochem (1995) 0.84
Identification and characterization of Magmas, a novel mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction. Exp Hematol (2001) 0.84
Binocular function in unilateral aphakia. Correlation with aniseikonia and stereoacuity. Ophthalmology (1988) 0.83
Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene (1996) 0.83
Protective effect of rifampicin against acute liver injury induced by carbon tetrachloride in mice. Jpn J Pharmacol (1995) 0.83
Specific binding of amyloid-beta-protein to IMR-32 neuroblastoma cell membrane. J Pept Res (2005) 0.83
Interleukin 12: newest member of the antiangiogenesis club. J Natl Cancer Inst (1995) 0.83
Purification and properties of glucose-6-phosphate dehydrogenase from Bacillus stearothermophilus. J Appl Biochem (1985) 0.83
Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice. Exp Hematol (1999) 0.83
Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay. J Pept Res (2001) 0.83
Cloning of human cDNAs for Apg-1 and Apg-2, members of the Hsp110 family, and chromosomal assignment of their genes. Gene (1999) 0.82
Effect of nitrous oxide on propofol requirement during target-controlled infusion for oocyte retrieval. Int J Obstet Anesth (2006) 0.82
TCR alpha beta-independent CD28 signaling and costimulation require non-CD4-associated Lck. J Immunol (1999) 0.82
Biochemical genetics of the mouse IgM system. Can J Biochem Cell Biol (1984) 0.82
Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity. Blood (1999) 0.82
Expression of brain-derived neurotrophic factor, neurotrophin-3 and their receptor messenger RNAs in monkey rhinal cortex. Neuroscience (2000) 0.81
Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro. Clin Exp Metastasis (1998) 0.81
High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Stem Cells (2001) 0.81
Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12. Hum Gene Ther (1997) 0.81
Novel approaches to prodrugs of anticancer diaminodichloroplatinum(II) complexes activated by stereoselective enzymatic ester hydrolysis. J Inorg Biochem (1998) 0.81
Preparation of functional liposomes with peptide ligands and their binding to cell membranes. Lipids (2000) 0.81
Development of a double-copy bicistronic retroviral vector for human gene therapy. Adv Exp Med Biol (1998) 0.81
Identification of sequence-tagged transcripts differentially expressed within the human hematopoietic hierarchy. Genomics (1998) 0.81
Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance. Cancer Res (1995) 0.80
Cloning and expression analysis of a novel WD repeat gene, WDR3, mapping to 1p12-p13. Genomics (1999) 0.80
Highest trkB mRNA expression in the entorhinal cortex among hippocampal subregions in the adult rat: contrasting pattern with BDNF mRNA expression. Brain Res Mol Brain Res (1998) 0.80
Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor. Hum Gene Ther (1995) 0.80
Expression of retrovirally transduced IL-1 alpha in IL-6-dependent B cells: a murine model of aggressive multiple myeloma. Growth Factors (1991) 0.80
Bidirectional modulation of TNF-alpha production by alveolar macrophages in asbestos-induced pulmonary fibrosis. J Leukoc Biol (1993) 0.80